| Event Name | Start Date | City | Region | Days Until |
|---|
| Biopharmaceutical Development & Production | February 27, 2012 | San Diego | CA | 21 |
| Molecular Medicine Tri-Conference | February 19, 2012 | San Francisco | CA | 13 |
| Phase I & IIa Clinical Trials | February 21, 2012 | London | UK | 15 |
| BioPartnering North America | February 26, 2012 | Vancouver | BC | 20 |
| Cold Chain & Temperature Management Summit | February 27, 2012 | Toronto | Canada | 21 |
| Viral Safety for Biologicals | February 27, 2012 | San Diego | CA | 21 |
| Biopharmaceutical Raw Materials throughout the Product Lifecycle | February 27, 2012 | San Diego | CA | 21 |
| Rare Diseases Leaders' Forum | March 12, 2012 | San Francisco | CA | 35 |
| Autoimmune & Inflammation Leaders | March 12, 2012 | San Francisco | CA | 35 |
| Metabolic Leaders Forum | March 12, 2012 | San Francisco | CA | 35 |
| BIO-Europe Spring 2012 | March 19, 2012 | Amsterdam | The Netherlands | 42 |
| Phacilitate Active Immunotherapy Leaders’ Forum | May 9, 2012 | Barcelona | Spain | 93 |
